Molecular Carcinogenesis

Papers
(The H4-Index of Molecular Carcinogenesis is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
46
Issue Information ‐ Ed Board45
Cover Image, Volume 62, Issue 443
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery35
Combined Inhibition of XPO1 and DNA Methylation Exerts Synergistic Effects in DLBCL33
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer31
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer29
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway27
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance26
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells26
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination24
CRISPR‐Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer24
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer23
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis23
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling23
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner23
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression22
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation21
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway20
Issue Information ‐ Ed Board19
19
19
Issue Information ‐ Ed Board19
0.13079905509949